The venture capital arms of Pittsburgh-based UPMC and UChicago Medicine have invested in a healthcare AI startup as part of a $55 million series C funding round.
UPMC Enterprises and UCM Ventures backed Ultromics, which says it offers the first FDA-cleared, Medicare-reimbursed AI technology to aid in detecting cardiac amyloidosis and heart failure with preserved ejection fraction. The company developed the tool in collaboration with Rochester, Minn.-based Mayo Clinic.
Ultromics’ other health system partners include Cleveland-based University Hospitals and Chicago-based Northwestern Medicine. The startup says its platform helps hospitals cut unnecessary tests, enhance workflows and start treatments earlier.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.